Cargando…
Stereotactic radiosurgery for patients with breast cancer brain oligometastases — molecular subtypes and clinical outcomes
BACKGROUND: We sought to determine the clinical outcomes of patients with breast cancer (BC) who had undergone stereotactic radiosurgery (SRS) for a limited number of brain metastases (BM) and to identify factors influencing overall survival (OS) and local control. MATERIALS AND METHODS: The records...
Autores principales: | Ratosa, Ivica, Vidmar, Marija Skoblar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086712/ https://www.ncbi.nlm.nih.gov/pubmed/33948296 http://dx.doi.org/10.5603/RPOR.a2021.0001 |
Ejemplares similares
-
Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019) -
Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020) -
Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer
por: Haque, Waqar, et al.
Publicado: (2021) -
Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
por: Jeromen, Ana, et al.
Publicado: (2012) -
Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)